Statistics for Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age
Total visits
views | |
---|---|
Safety and immunogenicity of an MF59 (R)-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age | 82 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
Safety and immunogenicity of an MF59 (R)-adjuvanted A H1N1 pandemic influenza vaccine in children from three to seventeen years of age.pdf | 5 |
Top country views
views | |
---|---|
United States | 44 |
Chile | 25 |
Mexico | 1 |
Top city views
views | |
---|---|
Miami | 37 |
Santiago | 20 |
Alameda | 5 |
Concepcion | 5 |
Campbell | 1 |
Sacramento | 1 |
Zapopan | 1 |